| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.52 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |